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Summary
Jérôme Lejeune’s greatest achievement was the discovery of the genetic basis of down’s 
syndrome, which he named trisomy 21. His important research in human genetics, as well 
as his humanitarian spirit and fight against therapeutic abortion, rightly led to his recognition 
as the founder of modern genetics. 
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introduction
Down’s syndrome was considered to be a racial defect for over one 
hundred years. Scientists presupposed the regression of certain typical 
features of a race towards race. Due to these presuppositions, Down’s 
syndrome was viewed with indifference or contempt by the scientific com-
munity. The general public held the parents of affected children responsi-
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ble, accusing them of being alcoholics or suffering from syphilis. Ten years 
after the Nazi concentration camps and ten years before the first manipu-
lations on embryos, jérôme Lejeune revolutionized this scientific field. 
Not only was he the first to recognize that Down’s syndrome was linked to 
a chromosomal aberration, but more importantly, he revived the 
Hippocratic medical ethics, supporting that man does not belong to a race 
that declines when he becomes sick.  
life, career, and diStinctionS
jérôme Lejeune was born on june 13, 1926 in Montrouge, just outside 
Paris. He studied medicine in Paris and received his diploma in 1951. In 
1952, he joined C.N.R.S. (National Center for Scientific Research) as 
director of research and a French delegate for atomic radiation [1] (Fig. 
1). On june 24, 1960, Lejeune received his doctoral degree in science with 
a thesis entitled “Le mongolisme” [2] and in 1964, he was appointed profes-
sor of fundamental genetics. He is the first and only French geneticist who 
received the kennedy Prize from the president of the United States john 
F. kennedy as the highest scientific distinction for his groundbreaking 
research in 1962. In 1969, he received the Memorial Allen Award Medal 
and in 1993 the Leopold Griffuel Prize for his pioneering research on 
chromosomal abnormalities in cancer.
jérôme Lejeune was a member of the Pontifical Academy of Sciences 
(1974), the Academy of Moral and Political Sciences in Paris (1981), the 
National French Academy of Medicine, the American Academy of Arts 
and Sciences, the Academies of Sweden, Argentina, and Chile, and pre-
sided over the Pontifical Academy of Life (1994). He was a friend and 
close collaborator of Pope john Paul II in opposing abortion. Lejeune died 
of lung cancer on April 3, 1994. A state-approved jérôme Lejeune 
Foundation for research into the genetics of mental retardation and the 
care of the mentally ill has been named in his honor [3], [4]. On june 28, 
2007 the cause for canonization of jérôme Lejeune was introduced, 
acknowledging the heroic soul of this pro-life geneticist [5].
the “triSomy 21 “: leujene’S leadinG diScovery
The stigma of Down’s or “Mongolian” children goes way back in history. 
The physical resemblance of Down’s syndrome patients to Mongolians 
(individuals of the Mongolian race) led to this association. In 1866, Sir 
john Langdon Haydon Down [6] described the so called “Mongolian idi-
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ocy”. However, later investigations in medical 
history proved that this syndrome was not origi-
nally described by Down, but rather by jean 
Etienne Dominique Esquirol in 1838 [7] and by 
Edouard Seguin in 1846 [8]. 
The idea that Down’s syndrome might be 
due to a chromosomal anomaly had been pro-
posed repeatedly through the works of Turpin 
and Alexandre Caratzali in 1937 [9], Penrose 
[10] and Fanconi [11] in 1939, and Ursula 
Mittwoch [12] in 1952. However, it was 
Lejeune who first demonstrated the presence of 
a supernumerary chromosome in these patients. 
In 1953, jérôme Lejeune and his teacher 
Raymond-Alexandre Turpin (1895-1988), who had long been interested 
in the disease, demonstrated the connection between dermatoglyphics 
and the physical and psychic characteristics of the patients [14]. Lejeune 
then proceeded to study the factors implicated in Down’s syndrome 
pathogenesis. He recorded its frequency at birth (1 in 600) and observed 
that immaturity as well as ageing coul lead to the production of abnormal 
gametes. In a study of 144 cases of twins, he included at least one case 
with Down’s syndrome and he concluded that it was a condition unre-
lated to the uterine environment or potential fetal trauma [15]. 
Summarizing his findings, Lejeune concluded that Down’s syndrome was 
a constitutional disease arising at the time of embryo formation, was influ-
enced by non hereditary factors, and was a genetic entity: “the only 
hypothesis that can explain its occurrence is the case of a ‘chromosomal 
accident ‘, concerning a large number of genes.” [15].  To prove his 
hypothesis, in 1958 Lejeune began culturing tissues from children with 
Down’s syndrome in order to observe their chromosomes and established 
an original technique of chromosomal examination. He confirmed exper-
imentally the fundamental concept first described in 1956 that the num-
ber of chromosomes in healthy human cells is 46 [16]. His in-depth 
chromosomal studies revealed for the first time in 1958 the presence of an 
additional small 47th chromosome in one of the Down’s syndrome cases he 
was investigating. At that time, staining techniques could not identify the 
chromosomal origin of this 47th chromosome, which led him to consider 
two possibilities; either this was one chromosome in excess or a chromo-
some that broke in two. 
jérôme Lejeune  
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At the end of january 26, 1959, Lejeune reported his findings to the 
Academy of Sciences journal under the title Les chromosomes humains en 
culture de tissus [13]. On March 16, 1959, with another communication 
entitled L’étude des chromosomes somatiques de neuf enfants mongoliens [17] 
he provided evidence to support that this 47th chromosome was morpho-
logically identical to chromosome 21. The presence of three copies of the 
same chromosome led to the use of the term “trisomy”, arising from the 
Greek treis (three) and soma (body), and since this involved the chromo-
some pair 21, Lejeune named the disease “trisomy 21”.
During the same year, Lejeune presented his findings to the French 
Academy of Sciences. He began his speech by regretting that this disease 
was not originally described by an Asian doctor, who would have avoided 
attributing racial connotations to Down’s syndrome. He then summarized 
the physical and mental characteristics of these patients with the follow-
ing words: “The face is flat and broad and destitute of prominence. The 
cheeks are roundish and extended laterally. The eyes are obliquely placed 
and the internal canthi more than normally distant from one another. The 
palpebral fissure is very narrow. […] The lips are large and thick with 
transverse fissures. The tongue is long, thick and much roughened. The 
nose is small.” [13]. He clarified that Down’s syndrome was seen in indi-
viduals of all races and that its specific phenotypic characteristics would 
modify with age, resulting in distinct malformations that were however, 
unrelated to the Mongolian or any other race [13]. Concerning the men-
tal disabilities that accompany the syndrome, Lejeune described a handi-
cap towards the understanding of abstract notions and a decline in IQ 
with age, contrary to unaffected individuals, while the process of memory 
appeared to be less affected. He further added that these patients had a 
very loving nature and a cheerful character [13]. 
Lejeune’s discovery of a chromosomal abnormality as the cause of a 
human disease represents a hallmark in human medical genetics, which 
contributed to the birth of clinical cytogenetics and opened the way to a 
new era towards deciphering human pathology.
lejeune’S controverSial fiGht aGainSt theraPeutic 
abortion
In his later years, jérôme Lejeune became an outspoken defender of 
human life, speaking frequently against abortion. Noticing a high ten-
dency of physicians to recommend therapeutic abortion to prevent the 
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birth of children with Down’s syndrome and considering embryo as a 
person, in 1971, Lejeune initiated an antiabortion movement named 
“Laissez-les vivre” (Let Them Live) [18]. In one of his speeches, Lejeune 
says: “From the fertilized egg to adult life, a man is the same human being 
that matures and dies… There are his peculiarities that make him irre-
placeable…. As medicine assists in the care at the end of life?, so it has to 
protect its beginning” and he continues “in face of distress caused by a 
diagnosis of a disease, the physician must assist the mother and the child. 
So deliberate interruption of a pregnancy for reasons of eugenics or for 
resolving a moral, economic or social issue is not for a doctor to perform?” 
[19], [20]. This famous text received support of at least 20,000 doctors 
and shed new light on the question of abortion. Lejeune was the indisput-
able leader of the opponents against the legalization of abortion, as he 
considered that the life of an individual was valuable as early as his time 
in the uterus. Furthermore, he asked for fetuses to be legally recognized as 
“people” right from their conception. This position enticed opposition to 
his scientific work and led to a series of public insults, media attacks, 
criticism of his research from 1982 onwards, and finally to destroying his 
chances to get the Nobel Prize for his groundbreaking discovery.
In the meantime, as a member of the Pontifical Council for Health 
Care Workers and the President of the Pontifical Academy of Life, he was 
appointed to study the relationships between biomedicine and Christian 
morals [4], [18].
concluSion
Lejeune’s work demonstrated the clear distinction between Down’s 
syndrome and race, revolutionized our understanding of chromosomal 
contribution to disease pathogenesis, and set the foundations for clinical 
cytogenetics and medical genetics. jérôme Leujene truly led the way to a 
new era in human genetics.
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Sažetak
Najveće postignuće Jérômea Lejeunea bilo je otkriće genetske osnove downova sindroma, 
koju je nazvao trisomija 21. Zahvaljujući važnim humanim genetičkim istraživanjima, 
humanitarnome duhu i borbi protiv terapijskoga pobačaja, s pravom je priznat kao ute‑
meljitelj moderne genetike. 
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